Advanced CPhT key terms

An approved list of medications that a health system or insurance plan prefers to stock and cover, maintained by a pharmacy and therapeutics committee that reviews safety, efficacy, and cost.

A protocol-approved substitution of a chemically different but therapeutically similar drug for the one that was prescribed, made without contacting the prescriber because the agents are considered clinically equivalent.

A structured, ongoing quality review of how a drug is prescribed, dispensed, administered, and monitored, used to find and correct gaps between actual and desired practice.

The date after which a prepared, opened, or compounded product must be discarded because its sterility, potency, or stability can no longer be assured; assigned from stability data or USP standards.

The device, such as a laminar airflow hood or compounding isolator, that supplies the ISO-classified air where sterile compounding occurs; the surrounding cleanroom is the secondary engineering control.

A computerized unit on a patient care unit that stores and dispenses medications, tracks inventory, and restricts access by user, linking each removal to a patient or an override reason.

An integrated electronic system in which prescribing, verification, dispensing, administration, and documentation are linked and confirmed at each step, ideally with barcode verification at the bedside.

A practice, permitted only where state law and organizational policy allow, in which a trained and validated pharmacy technician verifies another technician's work instead of a pharmacist.

The process of anticipating, tracking, and mitigating supply interruptions through conservation, therapeutic alternatives, allocation decisions, and communication with prescribers, staff, and patients.

Any harm a patient experiences that is related to a medication, whether or not the reaction was predictable, including harm arising from prescribing, dispensing, administration, or monitoring mistakes.

A preventable mistake at any stage of the medication process, from prescribing through monitoring, that could cause harm, regardless of whether harm actually reached the patient.

A drug that carries an increased risk of substantial patient harm when used in error; common classes include anticoagulants, insulin, opioids, and concentrated electrolytes.

Drug names or packaging that can be confused with one another when written, spoken, or stored, making them a leading source of wrong-drug errors.

A formatting convention that capitalizes the distinguishing syllables of easily confused drug names so prescribers, technicians, and nurses can spot the difference at a glance.

A structured retrospective investigation of a serious event that maps contributing factors and system failures, then produces corrective actions aimed at prevention rather than at blaming individuals.

A proactive, team-based method that lists each step of a process, ranks how and how badly it could fail, and targets the highest-risk steps before any harm occurs.

An organizational model that treats human error as a system issue while still holding people accountable for reckless behavior, which encourages staff to report problems without fear.

A rapid-cycle improvement method in which a team plans a small change, carries it out, studies the results, then adopts, adapts, or abandons it before starting the next cycle.

A verification process in which two qualified people separately check a high-risk calculation, product, or dose without sharing findings first, reducing the chance they make the same mistake.

An unexpected occurrence involving death, serious physical or psychological injury, or the risk of such outcomes, that signals an immediate need for investigation and response.

A screening method that scans records for warning signals, such as an antidote order or an abnormal laboratory value, that suggest a possible adverse event worth detailed review.

The federal category for drugs with high abuse potential and accepted medical use, such as oxycodone; prescriptions cannot be refilled and stricter storage and recordkeeping rules apply.

The order form, now largely replaced by the electronic CSOS system, that a registered purchaser must use to obtain Schedule I or Schedule II drugs from a distributor.

A continuously updated record of controlled substances in which each receipt and dispensing is logged so the expected balance can be compared with the physical count at any time.

A complete, documented count of all controlled substances on hand that DEA regulations require every registrant to perform at least once every two years.

The report a registrant files with DEA when controlled substances are discovered lost or stolen, describing the drugs involved, quantities missing, and the circumstances of the loss.

A state-run database that collects dispensed controlled substance prescriptions so prescribers and pharmacists can review a patient's history for duplication, high-risk combinations, or misuse.

The pharmacist's legal duty to resolve red flags and confirm that a controlled substance prescription was issued for a legitimate medical purpose by a prescriber acting in the usual course of practice.

An FDA-required safety plan that may use patient registries, prescriber certification, restricted distribution, or mandatory counseling to manage a medicine's serious known risks.

A federal law requiring transaction documentation and unit-level serialization so that prescription drugs can be traced and verified as they move through the distribution chain.

A pattern in a prescription or patient presentation, such as cash payment for a large quantity of a controlled substance or long travel distance, that suggests diversion and must be resolved before dispensing.

A collaborative conversation style using open questions, reflective listening, and affirmation to strengthen a patient's own reasons for change, rather than advising, warning, or arguing.

A counseling technique in which the patient restates information in their own words so the educator can confirm understanding and correct any gaps before the patient leaves.

A person's ability to obtain, process, and act on health information; limited health literacy calls for plain language, pictures, and limiting how many messages are delivered at once.

The extent to which a patient takes medication as prescribed, including starting, timing, dose, and duration; it is distinct from persistence, which is continuing therapy over time.

A structured, interactive review of all of a patient's medications, including supplements, that produces a personal medication list and a written action plan for the patient.

A patient-centered service in which a pharmacist assesses the entire medication regimen, identifies and resolves problems, and documents recommendations, often alongside an interprofessional care team.

A standardized communication format covering Situation, Background, Assessment, and Recommendation, used to hand off patient information to a physician or nurse clearly, completely, and briefly during urgent situations.

The ability to recognize how a patient's beliefs, language, and background shape health decisions, and to adapt communication and care so the plan fits that patient's reality.